Crocs Partners With Susan G. Komen to Fight Breast Cancer During National Breast Cancer Awareness
Month
Crocs, Inc. (NASDAQ: CROX), a global leader in innovative casual footwear for women, men and children, today announced that it
has partnered with Susan G. Komen®, the world’s leading breast cancer organization, to support its fight to save lives through a
new, limited edition collection launching in time for National Breast Cancer Awareness month.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180919005081/en/
Crocs will donate to Susan G. Komen® $3 for each pair of Komen-licensed Classic Clogs sold from Oct. 1, 2018 to
Nov. 30, 2019 in connection with the Crocs Promotion, with a guaranteed minimum donation of $50,000. The Running Ribbon is a
registered trademark of Susan G. Komen®. (Photo: Business Wire)
On Oct. 1, 2018, Crocs will launch a new, limited edition collection throughout the United States, including its territories,
featuring Susan G. Komen’s iconic pink Running Ribbon. The special Komen edition Classic Clog (US MSRP of $49.99) and Jibbitz charm
(US MSRP of $1.99) will be available on crocs.com and at select stores and will expand to two additional styles for the
Spring/Summer 2019 season.
Crocs will donate to Susan G. Komen $3 for each pair of Komen-licensed Classic Clogs and $0.25 for each Komen-licensed Jibbitz
charm sold from Oct. 1, 2018 to Nov. 30, 2019 in connection with the Crocs Promotion, with a guaranteed minimum donation of
$50,000. The Running Ribbon included on these limited-edition products is a registered trademark of Susan G. Komen.
“Susan G. Komen’s leadership in breast cancer research and providing support for those in need across the country has set the
standard in providing hope and care for women and men who are impacted by breast cancer,” said Michelle Poole, Crocs Sr. Vice
President of Global Product and Marketing. “Crocs is proud to be a partner in Komen’s inspiring mission and is dedicated to helping
save lives from breast cancer through its brand values and actions.”
“We are excited that Crocs has joined with us to make a significant impact in the fight to end breast cancer, a disease that
claims more than 41,000 lives each year. Through this partnership, Crocs and its customers prove they are More Than Pink®,” said
Christina Alford, Komen’s Senior Vice President of Development. “We salute Crocs for its commitment and determination to help save
lives.”
About Crocs, Inc.
Crocs, Inc. (Nasdaq: CROX) is a world leader in innovative casual footwear for women, men and children, combining comfort and
style with a value that consumers know and love. Every pair of shoes within Crocs’ collection contains Croslite™ material, a
proprietary, molded footwear technology, delivering extraordinary comfort with each step.
In 2018, Crocs reinforces its mission of “everyone comfortable in their own shoes” with the second year of its global Come As
You Are™ campaign. To learn more about Crocs or Come As You Are, please visit
www.crocs.com or follow @Crocs on Facebook, Instagram and Twitter.
About Susan G. Komen®
Susan G. Komen is the world’s largest breast cancer organization, funding more breast cancer research than any other nonprofit
outside of the federal government while providing real-time help to those facing the disease. Komen has set a Bold Goal to reduce
the current number of breast cancer deaths by 50 percent in the U.S. by 2026. Since its founding in 1982, Komen has funded more
than $956 million in research and provided more than $2.1 billion in funding to screening, education, treatment and psychosocial
support programs serving millions of people in more than 60 countries worldwide. Komen was founded by Nancy G. Brinker, who
promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy’s life. That promise has become Komen’s
promise to all people facing breast cancer. Visit
komen.org or call 1-877 GO KOMEN. Connect with us on social at
ww5.komen.org/social.
Crocs, Inc.
Ryan Roccaforte, 720-378-1046
Rroccaforte@crocs.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20180919005081/en/